Mar 15, 2020 | All News, Research and Clinical Trials
The Neuroendocrine Tumor Research Foundation (NETRF) reports progress in the development of neuroendocrine tumor (NET) cell lines to help eliminate a decades-old obstacle in laboratory research. To stimulate progress in NET cell lines, NETRF established a Cell Line...
Mar 2, 2020 | All News, INCA
INCA is excited to announce that the paper “Unmet needs in the international neuroendocrine tumor (NET) community: Assessment of major gaps from the perspective of patients, patient advocates and NET healthcare professionals” is published in the March...
Feb 29, 2020 | All News, Awareness and Information
The MIND the Gap campaign was launched in 2019 by Neuroendocrine Cancer UK and recently showcased its aims and offered services at the British Psychosocial Oncology Society’s Conference, which took place in Edinburgh on February 26-28 this year. Neuroendocrine Cancer...
Feb 28, 2020 | All News, Awareness and Information
The Unicorn Foundation is excited to announce that it will be rebranding to NeuroEndocrine Cancer Australia from next month. After ten years since its inception, the Unicorn Foundation has become a well-respected name within the neuroendocrine cancer community. Yet...
Feb 23, 2020 | All News, Awareness and Information
The Carcinoid Cancer Foundation hosted a special Facebook Live Event on February 11, featuring neuroendocrine tumor (NET) expert Dr. M. Sue O’Dorisio, to discuss challenges that children, teens and young adults with NETs face. Participants were able to submit...
Feb 22, 2020 | All News, Awareness and Information
After canvassing AMEND’s membership in 2019 about potential rebranding, it became evident that AMEND’s existing SDH / PPGL Syndrome members were the only community that did not feel that the AMEND branding reflected their diseases well enough. AMEND therefore took the...
